Neuroimmunology
- Number of publications
- 123
Publications
-
Gonzalo, H; Nogueras, L; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Martin-Gari, M; Canudes, M; Peralta, S; Solana, MJ; Pamplona, R; Portero-Otin, M; Boada, J; Serrano JCE; Brieva, L
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Frontiers in Neuroscience 13 938-938. .
-
Nogueras, L; Gonzalo, H; Jove, M; Sol, J; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Solana, MJ; Peralta, S; Pamplona, R; Brieva, L
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
SCIENTIFIC REPORTS 9 11313-11313. .
-
Hervas-Garcia, JV; Pagani-Cassara, F
Chronic relapsing inflammatory optic neuropathy: a literature review
REVISTA DE NEUROLOGIA 68 524-530. .
-
Oreja-Guevara, C; Ayuso Blanco T; Brieva Ruiz L; Hernández Pérez MÁ; Meca-Lallana, V; Ramió-Torrentà L
Cognitive Dysfunctions and Assessments in Multiple Sclerosis
Frontiers in Neurology 10 581-581. .
-
Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo, G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II)
REVISTA DE NEUROLOGIA 68 468-479. .
-
Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)
REVISTA DE NEUROLOGIA 68 431-441. .
-
Hervas-Garcia, JV; Ramio-Torrenta, L; Brieva-Ruiz, L; Batlle-Nadal, J; Moral, E; Blanco, Y; Cano-Orgaz, A; Presas-Rodriguez, S; Torres, F; Capellades, J; Ramo-Tello, C
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
EUROPEAN JOURNAL OF NEUROLOGY 26 525-532. .
-
González Mingot C; Juárez Turégano A; Bosch Gaya A; Brieva Ruiz L
Cardiogenic shock in clinically isolated syndrome
NEUROLOGIA 34 69-72. .
-
Quirant-Sanchez, B; Presas-Rodriguez, S; Mansilla, MJ; Teniente-Serra, A; Hervas-Garcia, JV; Brieva, L; Moral-Torres, E; Cano, A; Munteis, E; Navarro-Barriuso, J; Martinez-Caceres, EM; Ramo-Tello, C
Th1Th17(CM) Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
Mediators of Inflammation 2019 8147803-8147803. .
-
Quirant-Sanchez, B; Hervas-Garcia, JV; Teniente-Serra, A; Brieva, L; Moral-Torres, E; Cano, A; Munteis, E; Mansilla, MJ; Presas-Rodriguez, S; Navarro-Barriuso, J; Ramo-Tello, C; Martinez-Caceres, EM
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients
Cns Neuroscience & Therapeutics 24 1175-1184. .
-
Sepulveda, M; Aldea, M; Escudero, D; Llufriu, S; Arrambide, G; Otero-Romero, S; Sastre-Garriga, J; Romero-Pinel, L; Martinez-Yelamos, S; Sola-Valls, N; Armangue, T; Sotoca, J; Escartin, A; Robles-Cedeno, R; Ramio-Torrent, L; Presas-Rodriguez, S; Ramo-Tello, C; Munteis, E; Pelayo, R; Gubieras, L; Brieva, L; Ortiz, N; Hervas, M; Mañé-Martínez MA; Cano, A; Vela, E; Tintore, M; Blanco, Y; Montalban, X; Graus, F; Saiz, A
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
MULTIPLE SCLEROSIS JOURNAL 24 1843-1851. .
-
Gil, A; Pardinas, B; Hervas, V; Lecina, J; Solana, MJ; Peralta, S; Forne, C; Gonzalez, C; Gonzalo, H; Nogueras, L; Brieva, L
Pilot Study of Telemedicine in multiple sclerosis to evaluate the effectiveness of a telecommunication system for the detection of the clinical activity of the disease in the number of relapses with respect to the standard clinical practice. TELEM
MULTIPLE SCLEROSIS JOURNAL 24 795-796. .